Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


27.08.2018

6 BMC Cancer
1 Breast Cancer
7 Breast Cancer Res Treat
1 Cancer
1 Clin Breast Cancer
2 Clin Cancer Res
1 Clin Exp Metastasis
1 Eur J Cancer
1 Int J Cancer
1 Int J Oncol
1 J Biol Chem
2 J Clin Oncol
1 Lancet
1 Mod Pathol
4 NPJ Breast Cancer
2 Oncol Rep
2 PLoS One
5 Radiology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Cancer

  1. HULTSCH S, Kankainen M, Paavolainen L, Kovanen RM, et al
    Association of tamoxifen resistance and lipid reprogramming in breast cancer.
    BMC Cancer. 2018;18:850.
    PubMed     Text format     Abstract available

  2. KUMAR D, Haldar S, Gorain M, Kumar S, et al
    Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway.
    BMC Cancer. 2018;18:52.
    PubMed     Text format     Abstract available

  3. KAEWKANGSADAN V, Verma C, Eremin JM, Cowley G, et al
    Tumour-draining axillary lymph nodes in patients with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC): the crucial contribution of immune cells (effector, regulatory) and cytokines (Th1, Th2) to immune-mediated tumo
    BMC Cancer. 2018;18:123.
    PubMed     Text format     Abstract available

  4. BEGUINOT M, Dauplat MM, Kwiatkowski F, Lebouedec G, et al
    Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ.
    BMC Cancer. 2018;18:129.
    PubMed     Text format     Abstract available

  5. HERNANDEZ RK, Wade SW, Reich A, Pirolli M, et al
    Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States.
    BMC Cancer. 2018;18:44.
    PubMed     Text format     Abstract available

  6. FUMET JD, Wickre M, Jacquot JP, Bizollon MH, et al
    Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer.
    BMC Cancer. 2018;18:839.
    PubMed     Text format     Abstract available


    Breast Cancer

  7. AYGIN D, Bozdemir H
    Exposure to violence in breast cancer patients: systematic review.
    Breast Cancer. 2018 Aug 22. pii: 10.1007/s12282-018-0900.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  8. BALLINGER TJ, Reddy A, Althouse SK, Nelson EM, et al
    Impact of primary breast cancer therapy on energetic capacity and body composition.
    Breast Cancer Res Treat. 2018 Aug 22. pii: 10.1007/s10549-018-4924.
    PubMed     Text format     Abstract available

  9. RAMOS J, Das J, Felty Q, Yoo C, et al
    NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
    Breast Cancer Res Treat. 2018 Aug 20. pii: 10.1007/s10549-018-4905.
    PubMed     Text format     Abstract available

  10. SONG EJ, Lee CW, Jung SY, Kim BN, et al
    Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer.
    Breast Cancer Res Treat. 2018 Aug 21. pii: 10.1007/s10549-018-4915.
    PubMed     Text format     Abstract available

  11. ALTUNDAG K
    Elevated BMI might more significantly affect the outcome negatively in luminal type breast cancer patients with brain metastases.
    Breast Cancer Res Treat. 2018 Aug 24. pii: 10.1007/s10549-018-4934.
    PubMed     Text format    

  12. BAE SY, Nam SJ, Jung Y, Lee SB, et al
    Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer.
    Breast Cancer Res Treat. 2018 Aug 21. pii: 10.1007/s10549-018-4928.
    PubMed     Text format     Abstract available

  13. WANG B, Yuan F
    The association between estrogen receptor alpha gene rs746432 polymorphism and the risk of breast cancer.
    Breast Cancer Res Treat. 2018 Aug 21. pii: 10.1007/s10549-018-4929.
    PubMed     Text format    

  14. BEMANIAN V, Noone JC, Sauer T, Touma J, et al
    Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer.
    Breast Cancer Res Treat. 2018 Aug 21. pii: 10.1007/s10549-018-4927.
    PubMed     Text format     Abstract available


    Cancer


  15. Many Women With the Most Common Form of Breast Cancer Can Skip Chemotherapy: Study finds that approximately 70% of patients with this form of the disease do not need adjuvant chemotherapy.
    Cancer. 2018;124:3281-2382.
    PubMed     Text format    


    Clin Breast Cancer

  16. ALI OS, Shabayek MI, Seleem MM, Abdellateif HG, et al
    MicroRNAs 182 and 375 Sera Expression as Prognostic Biochemical Markers in Breast Cancer.
    Clin Breast Cancer. 2018 Jul 29. pii: S1526-8209(18)30232.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  17. MENDEZ O, Peg V, Salvans C, Pujals M, et al
    Extracellular HMGA1 promotes tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
    Clin Cancer Res. 2018 Aug 22. pii: 1078-0432.CCR-18-0517.
    PubMed     Text format     Abstract available

  18. MEIJER TG, Verkaik NS, Sieuwerts AM, van Riet J, et al
    Functional ex vivo assay reveals homologous recombination deficiency in breast cancer beyond BRCA gene defects.
    Clin Cancer Res. 2018 Aug 23. pii: 1078-0432.CCR-18-0063.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  19. PASTORIZA JM, Karagiannis GS, Lin J, Lanjewar S, et al
    Black race and distant recurrence after neoadjuvant or adjuvant chemotherapy in breast cancer.
    Clin Exp Metastasis. 2018 Aug 22. pii: 10.1007/s10585-018-9932.
    PubMed     Text format     Abstract available


    Eur J Cancer

  20. VAN MAAREN MC, Strobbe LJA, Smidt ML, Moossdorff M, et al
    Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years.
    Eur J Cancer. 2018;102:82-94.
    PubMed     Text format     Abstract available


    Int J Cancer

  21. MOLLER MH, Lousdal ML, Kristiansen IS, Stovring H, et al
    Effect of organised mammography screening on breast cancer mortality: A population-based cohort study in Norway.
    Int J Cancer. 2018 Aug 25. doi: 10.1002/ijc.31832.
    PubMed     Text format     Abstract available


    Int J Oncol

  22. LI B, Chen P, Wang J, Wang L, et al
    MicroRNA-1254 exerts oncogenic effects by directly targeting RASSF9 in human breast cancer.
    Int J Oncol. 2018 Aug 21. doi: 10.3892/ijo.2018.4530.
    PubMed     Text format     Abstract available


    J Biol Chem

  23. TEGOWSKI M, Fan C, Baldwin AS
    Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2.
    J Biol Chem. 2018 Aug 21. pii: RA118.003719. doi: 10.1074/jbc.RA118.003719.
    PubMed     Text format     Abstract available


    J Clin Oncol

  24. GINSBURG O, Brennan P
    Genetic Testing for Breast Cancer in the Era of Multigene Panels: Can We Make an Impact on Population Health?
    J Clin Oncol. 2018 Aug 21:JCO2018793307. doi: 10.1200/JCO.2018.79.3307.
    PubMed     Text format    

  25. ZHENG Y, Walsh T, Gulsuner S, Casadei S, et al
    Inherited Breast Cancer in Nigerian Women.
    J Clin Oncol. 2018 Aug 21:JCO2018783977. doi: 10.1200/JCO.2018.78.3977.
    PubMed     Text format     Abstract available


    Lancet

  26. WILLER H
    Breast cancer in Venezuela: back to the 20th century.
    Lancet. 2018;392:461-462.
    PubMed     Text format    


    Mod Pathol

  27. RIMM DL, Leung SCY, McShane LM, Bai Y, et al
    An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.
    Mod Pathol. 2018 Aug 24. pii: 10.1038/s41379-018-0109.
    PubMed     Text format     Abstract available


    NPJ Breast Cancer

  28. VAN DYK K, Bower JE, Crespi CM, Petersen L, et al
    Cognitive function following breast cancer treatment and associations with concurrent symptoms.
    NPJ Breast Cancer. 2018;4:25.
    PubMed     Text format     Abstract available

  29. HUANG SY, Franc BL, Harnish RJ, Liu G, et al
    Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis.
    NPJ Breast Cancer. 2018;4:24.
    PubMed     Text format     Abstract available

  30. HOLGADO E, Perez-Garcia J, Gion M, Cortes J, et al
    Is there a role for immunotherapy in HER2-positive breast cancer?
    NPJ Breast Cancer. 2018;4:21.
    PubMed     Text format     Abstract available

  31. BOUGHEY JC, Alvarado MD, Lancaster RB, Fraser Symmans W, et al
    Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint.
    NPJ Breast Cancer. 2018;4:26.
    PubMed     Text format     Abstract available


    Oncol Rep

  32. CHEN Y, Wei L, Zhang X, Liu X, et al
    3Bromopyruvate sensitizes human breast cancer cells to TRAILinduced apoptosis via the phosphorylated AMPKmediated upregulation of DR5.
    Oncol Rep. 2018 Aug 14. doi: 10.3892/or.2018.6644.
    PubMed     Text format     Abstract available

  33. OH YJ, Park SY, Seo YH
    The targeted inhibition of Hsp90 by a synthetic small molecule, DPide offers an effective treatment strategy against TNBCs.
    Oncol Rep. 2018;39:1775-1782.
    PubMed     Text format     Abstract available


    PLoS One

  34. YANG J, Min KW, Kim DH, Son BK, et al
    High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts.
    PLoS One. 2018;13:e0202113.
    PubMed     Text format     Abstract available

  35. CARIOU A, Rouzier R, Baffert S, Soilly AL, et al
    Multidimensional impact of breast cancer screening: Results of the multicenter prospective optisoins01 study.
    PLoS One. 2018;13:e0202385.
    PubMed     Text format     Abstract available


    Radiology

  36. GARCIA-TEJEDOR A, Guma A, Soler T, Valdivieso A, et al
    Radiofrequency Ablation Followed by Surgical Excision versus Lumpectomy for Early Stage Breast Cancer: A Randomized Phase II Clinical Trial.
    Radiology. 2018 Aug 21:180235. doi: 10.1148/radiol.2018180235.
    PubMed     Text format     Abstract available

  37. BREM RF
    Radiofrequency Ablation of Breast Cancer: A Step Forward.
    Radiology. 2018 Aug 21:181784. doi: 10.1148/radiol.2018181784.
    PubMed     Text format    

  38. EISENBERG AM, Eppelheimer CN, Fulop TA, Abramson LL, et al
    Case 256: Breast Implant-associated Anaplastic Large-Cell Lymphoma.
    Radiology. 2018;288:624-629.
    PubMed     Text format     Abstract available

  39. MENEZES GLG, Pijnappel RM, Meeuwis C, Bisschops R, et al
    Downgrading of Breast Masses Suspicious for Cancer by Using Optoacoustic Breast Imaging.
    Radiology. 2018 Apr 17:170500. doi: 10.1148/radiol.2018170500.
    PubMed     Text format     Abstract available

  40. MOSHINA N, Sebuodegard S, Lee CI, Akslen LA, et al
    Automated Volumetric Analysis of Mammographic Density in a Screening Setting: Worse Outcomes for Women with Dense Breasts.
    Radiology. 2018 Jun 26:172972. doi: 10.1148/radiol.2018172972.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: